Postdoctoral Fellow - Cardiovascular Biology and Oncology
- City of Hope
- Duarte, CA
- $30.00 - $33.13 / hour
- Closing date
- May 17, 2023
- Life Sciences, Biology, Oncology
- Position Type
- Full Time
- Organization Type
City of Hope is an independent biomedical research and treatment organization for cancer, diabetes, and other life-threatening diseases.
Founded in 1913, City of Hope is a leader in bone marrow transplantation and immunotherapy such as CAR T cell therapy. City of Hope's translational research and personalized treatment protocols advance care throughout the world. Human synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope™, a subsidiary launched in 2019 serves employers and their health care partners by providing access to City of Hope's specialized cancer expertise.
A National Cancer Institute-designated comprehensive cancer center and a founding member of the National Comprehensive Cancer Network, City of Hope is ranked among the nation's "Best Hospitals" in cancer by U.S. News & World Report and received Magnet Recognition from the American Nurses Credentialing Center. Its main campus is located near Los Angeles, with additional locations throughout Southern California and in Arizona.
City of Hope's commitment to Diversity, Equity, and Inclusion
We believe diversity, equity and inclusion is key in serving our mission to provide compassionate patient care, drive innovative discovery, and advance vital education focused on eliminating cancer and diabetes in all our communities. Our commitment to Diversity, Equity and Inclusion ensures we bring the full range of skills, perspectives, cultural backgrounds, and experiences to our work -- and that our teams align with the people we serve to build trust and understanding. We are dedicated to fostering a community that embraces diversity - in ideas, backgrounds, and perspectives; this is reflected in our work and represented in our people.
A Postdoctoral Fellowship opportunity is immediately available for the highly motivated individual in the laboratory of Dr. June-Wha Rhee in City of Hope's Department of Medicine, Division of Cardiology.
The lab's research focuses on understanding the biology underlying cancer therapy-induced cardiovascular complications by leveraging human-induced pluripotent stem cells (iPSCs) as well as patient samples, genomics and leading-edge computational biology.
There has been remarkable progress in cancer treatments resulting in improved long-term survival. However, cardiovascular complications related to these therapies can cause treatment interruptions and lead to worse oncologic and cardiovascular outcomes. Therefore, there is a critical need to better understand 1) why and through what mechanisms the cancer therapy-related cardiotoxicity occurs, 2) who is at risk and 3) how to mitigate or prevent this toxicity. Our lab is working toward addressing these questions so that cancer patients can safely be treated with life-saving cancer therapies. Specifically, we believe metabolism and biologic aging are critical in modulating this risk and are working to define their roles by leveraging genome editing technology, multi-omics and advanced bioinformatics utilizing patient-specific iPSCs and patient samples.
The goal of the Rhee Lab is to pioneer basic and translational research in cardio-oncology so that we can find a way to protect our cancer patients from any cardiovascular complications. For this, we will employ cutting-edge technologies, bioinformatics, and patient-specific stem cells.
The candidate will investigate molecular mechanisms of cancer therapy-induced cardiotoxicity, leveraging cutting-edge computational biology, genome editing technologies, and induced pluripotent stem cell models.
Basic education, experience and skills required for consideration:
- PhD or M.D. in molecular biology, genetics, biochemistry, cell biology, bioinformatics or related field
- Previous experience in iPSC and/or mouse models, cardiovascular biology, molecular biology, genetics, or bioinformatics is highly desired but not required.
As a condition of employment, City of Hope requires staff to comply with all state and federal vaccination mandates.
- For more information on Dr. June Rhee's lab please visit here
The estimated pay scale represents the typical [salary/hourly] range City of Hope reasonably expects to pay for this position, with offers determined based on several factors which may include, but not be limited to, the candidate's experience, expertise, skills, education, job scope, training, internal equity, geography/market, etc. This pay scale is subject to change from time to time.
City of Hope is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, religion, color, national origin, sex, sexual orientation, gender identity, age, status as a protected veteran, or status as a qualified individual with disability.
City of Hope, an innovative biomedical research, treatment and educational institution with over 5,000 employees, is dedicated to the prevention and cure of cancer and other life-threatening diseases and guided by a compassionate, patient-centered philosophy.
Founded in 1913 and headquartered in Duarte, California, City of Hope is a remarkable non-profit institution, where compassion and advanced care go hand-in-hand with excellence in clinical and scientific research. City of Hope is a National Cancer Institute designated Comprehensive Cancer Center and a founding member of the National Comprehensive Cancer Network, an alliance of the nation’s 20 leading cancer centers that develops and institutes standards of care for cancer treatment.
Get job alerts
Create a job alert and receive personalized job recommendations straight to your inbox.Create alert